Goldman Sachs
STJ

Goldman Sachs’s St Jude Medical STJ Stock Holding History

Goldman Sachs’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-314,700
Closed -$25.2M – 7265
2016
Q4 		$25.2M Buy
314,700
+10,500
+3% +$833K 0.01% 1801
2016
Q3 		$24.3M Buy
304,200
+96,200
+46% +$7.77M 0.01% 1741
2016
Q2 		$16.2M Buy
208,000
+204,000
+5,100% +$14.5M 0.01% 1954
2016
Q1 		$220K Sell
4,000
-13,800
-78% -$752K ﹤0.01% 5529
2015
Q4 		$1.1M Sell
17,800
-72,400
-80% -$4.57M ﹤0.01% 4202
2015
Q3 		$5.69M Buy
90,200
+3,400
+4% +$243K ﹤0.01% 2775
2015
Q2 		$6.34M Buy
86,800
+20,800
+32% +$1.5M ﹤0.01% 2745
2015
Q1 		$4.32M Buy
66,000
+5,800
+10% +$386K ﹤0.01% 3041
2014
Q4 		$3.92M Sell
60,200
-62,200
-51% -$4.01M ﹤0.01% 3219
2014
Q3 		$7.36M Sell
122,400
-14,700
-11% -$960K ﹤0.01% 2643
2014
Q2 		$9.49M Sell
137,100
-6,200
-4% -$402K ﹤0.01% 2408
2014
Q1 		$9.37M Buy
143,300
+110,700
+340% +$7.21M ﹤0.01% 2428
2013
Q4 		$2.02M Sell
32,600
-255,100
-89% -$14.8M ﹤0.01% 4051
2013
Q3 		$15.4M Buy
287,700
+56,500
+24% +$2.91M 0.01% 1831
2013
Q2 		$10.6M Buy
+231,200
New +$10M ﹤0.01% 2035

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Goldman Sachs's STJ Position: Q1 2017 in Review

Goldman Sachs sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,601,287 shares — an estimated $690M sold.

Goldman Sachs first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $690M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Goldman Sachs reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 8,601,287 St Jude Medical shares in Q1 2017, an estimated $690M.
  • Goldman Sachs first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Goldman Sachs's St Jude Medical position peaked at $690M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.